MENU
GRAL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

GRAIL (GRAL) Ownership - Who owns GRAIL?

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection... Show more

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
1.33B
P/E Ratio
N/A
Total Cash
602.75M
Projected Growth
N/A
Total Debt
62.16M
Revenue
134.29M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
16.72
Total Debt/Equity
N/A
Revenue/Share
3.96 USD as % of share price

Fundamentals

GRAL
Capitalization
1.33B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
603M
Total Cash/Share
16.72
Total Debt
62.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.96%
Revenue
134M
ROE
N/A
Book Value
2.32B
P/B Ratio
0.57
Cash Flow
N/A
Earnings
-11.71
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
36K
Current Ratio
9.23
Current Revenue Per Employee
35544.00
Dividends Per Share - Security
N/A
EBITDA
-447.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
-50.01
Revenue To Assets
-14.83
Shares Held By Institutions
1.12B
Shares Outstanding - Current
36M
Total Liabilities
388M
Total Volume MTD
N/A
Value
N/A
Gain YTD
106.779
View a ticker or compare two or three
GRAL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GRAL showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details